Indian In Vitro Diagnostics (IVD) Market By Product Type (IVD Equipment and IVD Reagents); Technology Type (Clinical Chemistry, Molecular Diagnostics, Immunoassay, Clinical Microbiology, Coagulation, Hematology, Urinalysis, Blood Gas & Electrolytes, and Others); Application Type (Oncology, Immunology, Infectious Disease, Cardiovascular, Metabolism, Nephrology, and Others); End-users (Hospitals, Laboratories, Point-of-Care, Home Care, Research Institutes, and Others) – Forecast up to 2025

August 2019 | 78 pages | ID: ICC5DB65AC28EN
Infoholic Research

Abstracts

Indian IVD Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025

[78 pages report] This market research report includes a detailed segmentation of the Indian IVD market by product type (IVD Equipment and IVD Reagents); by technology type (Clinical Chemistry, Molecular Diagnostics, Immunoassay, Clinical Microbiology, Coagulation, Hematology, Urinalysis, Blood Gas & Electrolytes, and Others); by Application type (Oncology, Immunology, Infectious Disease, Cardiovascular, Metabolism, Nephrology, and Others); by end-users (Hospitals, Laboratories, Point-Of-Care, Home Care, Research Institutes, and Others); by region (North America, Europe, Asia Pacific, and Rest of the World)

Overview of the Indian IVD Market

Infoholic’s market research report predicts that the “Indian IVD Market” will grow at a CAGR of ~13.0% during the forecast period 2019–2025. The market is immensely driven by the increase in the number of chronic and lifestyle-related disorders, increasing cancer incidences, growing awareness on the importance of early diagnosis and prevention, and improving access to healthcare facilities and diagnostic set-ups.

Diagnostic tests are frequently performed in public or private laboratories equipped with suitable and expensive instrumentation along with skilled and trained personnel for analysis. The diagnostics market is experiencing quick progress due to advancements in oncology, molecular diagnostics, point-of-care, and novel sectors such as companion diagnostics in both developed and developing economies. The market is driven by an increase in the elderly population, intensification of chronic diseases, pandemic situations in case of infectious diseases, and the growing importance of medical diagnostics.

The majority of the revenue is generated from the leading players in the market with dominating sales from Danaher Corporation, Abbott Laboratories, bioMerieux, F. Hoffmann-La Roche, Siemens, Sysmex Corp., Thermo Fisher Scientific, Transasia Bio-Medicals Ltd., Bio-Rad Laboratories, Ortho Clinical Diagnostic, QIAGEN N.V., and Shanghai Fosun Pharmaceutical Co. Ltd.

By Product Type:

• IVD Reagents
• IVD Equipment

IVD reagents holds the major share in the Indian IVD market followed by IVD equipments in 2018. Transasia Bio-Medicals is the leader of India’s IVD market with over 45,000 installation bases across India.

By Technology Type:

• Immunoassay
• Biochemistry
• Hematology
• Microbiology
• Blood Gas and Diagnostics
• Molecular Diagnostics
• Urinalysis
• Coagulation

Biochemistry holds a significant share in the Indian IVD market in 2018. It is to be noted that TB culture accounts for 15–20% of the overall molecular diagnostic nowadays. The increasing adoption of point-of-care testing is also driving the market locally in India.

By Application Type:

• Oncology
• Infectious Disease
• Diabetes
• Cardiology
• Nephrology
• Autoimmune Disease
• Others

The industry has reached new heights with significant technological advances and greater performance technologies. Advanced, state-of - the-art techniques are used to comprehend disease prognosis and thus strengthen the standard of sophistication of the industry respondents. .

By End Users:

• Hospitals
• Laboratories
• Home Care
• Academic and Research Institute
• Others

Hospitals hold major share in the Indian IVD market. Hospitals and reference laboratories are expecting the development of products that will provide reliable results at great speed to reduce wrong diagnosis and treatment time.

Indian IVD Market Research Competitive Analysis – There has been a paradigm shift arising in the implementation of technology and automation. The need for precise and rapid results has resulted in the implementation of high-end products for in-depth evaluation. The Indian government supports Public–Private Partnerships (PPPs) and other innovative schemes to enhance Indian IVD advancement. Foreign Direct Investment (FDI) and domestic study have been encouraged by the government to support the industry. The number of players in the segment offering quality products and after-sales services has risen.

Key Vendors:

• Danaher Corporation
• Abbott Laboratories
• bioMerieux
• F. Hoffmann-La Roche
• Siemens
• Transasia Bio-Medicals Ltd.

Key Competitive Facts

• The future growth of the Indian In Vitro Diagnostic market will be driven by Tier-II and Tier-III cities and that is where the price of the products and testing consumables will matter the most.
• Hospitals and reference laboratories are expecting the development of products that will provide reliable results at great speed to reduce wrong diagnosis and treatment time.

Benefits – The report provides complete details about the sub-segments of the Indian IVD market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the disease management in the upcoming years along with details of the existing pure-play companies and new players entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:

• Understanding the potential market opportunity with precise market size and forecast data.
• A detailed market analysis focusing on the growth of the Indian IVD industry.
• Factors influencing the growth of the Indian IVD market.
• In-depth competitive analysis of dominant and pure-play vendors.
• Prediction analysis of the Indian IVD market.
• Key insights related to major segments of the Indian IVD market.
• Latest market trend analysis impacting the buying behavior of the consumers.

Contents

1 INDUSTRY OUTLOOK

1.1 IVD Industry Structure and Overview
1.2 Major Market Factors and Growth Drivers
1.3 Total Addressable Market
1.4 Industry Trends

2 REPORT OUTLINE

2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 MARKET SNAPSHOT

3.1 Market Definition – Infoholic Research
3.2 Advantages of IVD
3.3 Importance of IVD
3.4 Segmented Addressable Market
3.5 Trends in the Indian In Vitro Diagnostics Market
3.6 Related Market

4 MARKET OUTLOOK

4.1 Market Segmentation
4.2 PESTEL Analysis
4.3 Porter 5 (Five) Forces

5 MARKET CHARACTERISTICS

5.1 DRO – Market Dynamics
  5.1.1 Drivers
    5.1.1.1 Economic growth, increasing population, urbanization, and rising healthcare expenditure per capita
    5.1.1.2 Sedentary lifestyle, increasing prevalence of smoking and alcohol consumption resulting in incidence of lifestyle-related chronic disorders, cancer, and infectious diseases
    5.1.1.3 Growing penetration of IVD testing in tier-II and III cities
    5.1.1.4 Growing market of biomarker-based and genetic testing in India
  5.1.2 Opportunities
    5.1.2.1 Point-of-care testing, near patient testing, and home-based testing products and services (direct-to-patient testing services)
    5.1.2.2 Adoption of fully automated systems in India and increasing number of phase-III clinical trials in India
  5.1.3 Restraints
    5.1.3.1 High costs of testing cancer, genetic disorders, and other disease
    5.1.3.2 Tightening regulatory requirements but lack of reimbursement policies
  5.1.4 DRO – Impact Analysis
  5.1.5 Key Stakeholders

6 IVD MARKET SEGMENTS: REAGENTS AND EQUIPMENT

7 TECHNOLOGY TYPES: MARKET SIZE AND ANALYSIS

7.1 Overview
7.2 Immunoassay
7.3 Biochemistry
7.4 Hematology
7.5 Microbiology
7.6 Blood Gas & Electrolytes
7.7 Molecular Diagnostics
7.8 Urinalysis
7.9 Coagulation

8 APPLICATIONS: MARKET SIZE AND ANALYSIS

8.1 Overview
8.2 Oncology
8.3 Infectious Disease
8.4 Diabetes
8.5 Cardiology
8.6 Nephrology
8.7 Autoimmune Disease
8.8 Others

9 END-USERS: MARKET SIZE AND ANALYSIS

9.1 Overview
9.2 Hospitals
9.3 Laboratories
9.4 Home Care
9.5 Academic and Research Institutes
9.6 Others

10 COMPETITIVE LANDSCAPE

10.1 Overview

11 VENDORS PROFILE

11.1 Abbott Laboratories
11.2 Danaher Corporation
11.3 bioMerieux
11.4 F. Hoffmann La Roche
11.5 Siemens
11.6 Transasia Bio-Medical Ltd

12 COMPANIES TO WATCH FOR

12.1 Sysmex Corporation
12.2 Thermo Fisher Scientific
12.3 Bio-Rad Laboratories
12.4 Ortho Clinical Diagnostic
12.5 QIAGEN N.V
12.6 Shanghai Fosun Pharmaceutical Co. Ltd
Annexure
  12.6.1 Abbreviations

List Of Tables

LIST OF TABLES

TABLE 1 CLASSFICATION OF INDIAN IVD MEDICAL DEVICES
TABLE 2 THE INDIAN IVD INDUSTRY STRUCTURE
TABLE 3 INDIAN IVD EQUIPMENT GROWTH RATES 2015–2020
TABLE 4 PORTERS FIVE FORCES ON INDIAN IVD MARKET
TABLE 5 MEGATRENDS DRIVING IVD MARKET IN INDIA
TABLE 6 BUSINESS SUMMARY: ABBOTT LABORATORIES
TABLE 7 BUSINESS SUMMARY: DANAHER CORPORATION
TABLE 8 BUSINESS SUMMARY: BIOMERIEUX
TABLE 9 BUSINESS SUMMARY: F. HOFFMANN LA ROCHE
TABLE 10 BUSINESS SUMMARY: SIEMENS
TABLE 11 BUSINESS SUMMARY: TRANSASIA BIO-MEDICAL LTD
TABLE 12 BUSINESS SUMMARY: SYSMEX CORPORATION
TABLE 13 BUSINESS SUMMARY: THERMO FISHER SCIENTIFIC
TABLE 14 BUSINESS SUMMARY: BIO-RAD LABORATORIES
TABLE 15 BUSINESS SUMMARY: ORTHO CLINICAL DIAGNOSTIC
TABLE 16 BUSINESS SUMMARY: QIAGEN N.V
TABLE 17 BUSINESS SUMMARY: SHANGHAI FOSUN PHARMACEUTICAL CO. LTD

List Of Figures

LIST OF FIGURES

CHART 1 IVD REGULATORY STRUCTURE IN INDIA
CHART 2 RESEARCH METHODOLOGY OF INDIAN IN VITRO DIAGNOSTICS MARKET
CHART 3 INDIA IN VITRO DIAGNOSTICS MARKET REVENUE, 2018–2025 ($BILLION)
CHART 4 INDIA DIAGNOSTIC IMAGING MARKET REVENUE, 2018–2025 ($BILLION)
CHART 5 SEGMENTATION OF THE INDIAN IN VITRO DIAGNOSTICS MARKET
CHART 6 PESTEL ANALYSIS OF INDIAN IN VITRO DIAGNOSTICS MARKET
CHART 7 MARKET DYNAMICS – DRO ANALYSIS
CHART 8 DRO – IMPACT ANALYSIS OF INDIAN IN VITRO DIAGNOSTICS MARKET
CHART 9 KEY STAKEHOLDERS
CHART 10 INDIA IN VITRO DIAGNOSTICS MARKET REVENUE, 2018–2025 ($BILLION)
CHART 11 INDIAN IVD REAGENT AND EQUIPMENT MARKET BY TECHNOLOGY TYPES, 2018 AND 2025 (%)
CHART 12 INDIAN IMMUNOASSAY MARKET FORECAST, 2018–2025 ($BILLION)
CHART 13 INDIA BIOCHEMISTRY MARKET FORECAST, 2018–2025 ($BILLION)
CHART 14 HEMATOLOGY MARKET FORECAST, 2018–2025 ($BILLION)
CHART 15 MICROBIOLOGY MARKET FORECAST, 2018–2025 ($BILLION)
CHART 16 BLOOD GAS & ELECTROLYTES MARKET FORECAST, 2018–2025 ($BILLION)
CHART 17 MOLECULAR DIAGNOSTICS MARKET FORECAST, 2018–2025 ($BILLION)
CHART 18 URNALYSIS MARKET FORECAST, 2018–2025 ($BILLION)
CHART 19 COAGULATION MARKET FORECAST, 2018–2025 ($BILLION)
CHART 20 INDIAN IN VITRO DIAGNOSTICS MARKET SHARE BY APPLICATION SEGMENTATION, 2018 (%)
CHART 21 INDIAN IN VITRO DIAGNOSTICS MARKET SHARE BY APPLICATION SEGMENTATION, 2025 (%)
CHART 22 ONCOLOGY MARKET FORECAST, 2018–2025 ($BILLION)
CHART 23 INFECTIOUS DISEASE MARKET FORECAST, 2018–2025 ($BILLION)
CHART 24 DIABETES MARKET FORECAST, 2018–2025 ($BILLION)
CHART 25 CARDIOLOGY MARKET FORECAST, 2018–2025 ($BILLION)
CHART 26 NEPHROLOGY MARKET FORECAST, 2018–2025 ($BILLION)
CHART 27 AUTOIMMUNE DISEASE MARKET FORECAST, 2018–2025 ($BILLION)
CHART 28 OTHER APPLICATIONS MARKET FORECAST, 2018–2025 ($BILLION)
CHART 29 INDIAN IN VITRO DIAGNOSTICS MARKET SHARE BY END-USERS SEGMENTATION, 2018 (%)